Hikari Sugawa
Hikari Sugawa publishes mostly in Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, on topics such as Advanced Glycation End Products research, Natural Antidiabetic Agents Studies and Alcohol Consumption and Health Effects.
- World rank
- #4,437,765 of 7,710,434 ranked researchers
- Rank in Japan
- #127,600 of 383,136
- Works
- 39
- Citations
- 466
- Citations per work
- 11.9
What does Hikari Sugawa research?
Hikari Sugawa's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (31%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1538.9%
- Health Sciences1230.6%
- Medicine1230.6%
- Everything else1230.5%
- 1Clinical Biochemistry25% of their works
- 2Endocrinology, Diabetes and Metabolism17% of their works
- 3Pathology and Forensic Medicine9% of their works
- 4Molecular Biology9% of their works
- 5Physiology5% of their works
- 6Neurology5% of their works
Research topics
- Advanced Glycation End Products research
- Natural Antidiabetic Agents Studies
- Alcohol Consumption and Health Effects
- Phytoestrogen effects and research
- Neurological Disease Mechanisms and Treatments
- Phytochemicals and Antioxidant Activities
- Diet, Metabolism, and Disease
- Phytochemistry and Biological Activities
Which keywords describe Hikari Sugawa's research?
The keywords of their largest research topics: Oxidative Stress, Diabetes, Inflammation, Advanced Glycation End Products, HMGB1, Flavonoids, Antioxidants and Insulin Resistance.
- Antioxidant
- Polyphenols
- Fructose
- Cerebral Hypoperfusion
- Phytoestrogens
- Alcohol
- Bioavailability
- Cardiovascular Health
- Alpha-Glucosidase Inhibitors
- Insulin Resistance
- Flavonoids
- Advanced Glycation End Products
- Diabetes
- Oxidative Stress
- Inflammation
- HMGB1
- Antioxidants
- Medicinal Plants
- Type 2 Diabetes
- Metabolism
- Cancer Prevention
- Liver Disease
- Soy Isoflavones
- Free Radicals
- Metabolic Syndrome
- Vascular Cognitive Impairment
- Phytochemistry
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 27 words, with their numbers
- Oxidative Stress525 topics
- Diabetes402 topics
- Inflammation332 topics
- Advanced Glycation End Products271 topic
- HMGB1271 topic
- Flavonoids183 topics
- Antioxidants162 topics
- Insulin Resistance162 topics
- Medicinal Plants152 topics
- Alpha-Glucosidase Inhibitors131 topic
- Type 2 Diabetes131 topic
- Cardiovascular Health102 topics
- Metabolism102 topics
- Bioavailability72 topics
- Cancer Prevention72 topics
- Alcohol61 topic
- Liver Disease61 topic
- Phytoestrogens41 topic
- Soy Isoflavones41 topic
- Cerebral Hypoperfusion31 topic
- Free Radicals31 topic
- Fructose31 topic
- Metabolic Syndrome31 topic
- Polyphenols31 topic
- Vascular Cognitive Impairment31 topic
- Antioxidant21 topic
- Phytochemistry21 topic
Where does Hikari Sugawa work?
Hikari Sugawa's main affiliation in the publication record is Kyushu Tokai University, Japan.
How many publications and citations does Hikari Sugawa have?
OpenAlex counts 39 works and 466 citations for Hikari Sugawa, an h-index of 15, ranking #4,437,765 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hikari Sugawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.